Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > INKT MiNK Therapeutics > Detailed Quotes

INKT MiNK Therapeutics

Watchlist
2.220
+0.070+3.26%
Close  02/03 16:00 ET
2.2200.0000.00%
Post Mkt Price 02/03 16:26 ET
High
2.270
Open
2.060
Turnover
18.02K
Low
2.060
Pre Close
2.150
Volume
8.15K
Market Cap
75.00M
P/E(TTM)
Loss
52wk High
4.320
Shares
33.79M
P/E(Static)
Loss
52wk Low
1.090
Float Cap
9.94M
Bid/Ask %
60.00%
Historical High
22.155
Shs Float
4.48M
Volume Ratio
0.67
Historical Low
1.090
Dividend TTM
--
Div Yield TTM
--
P/B
11.10
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.18%
Amplitude
9.77%
Avg Price
2.211
Lot Size
1
Float Cap
9.94M
Bid/Ask %
60.00%
Historical High
22.155
Shs Float
4.48M
Volume Ratio
0.67
Historical Low
1.090
Dividend TTM
--
P/B
11.10
Dividend LFY
--
Turnover Ratio
0.18%
Amplitude
9.77%
Avg Price
2.211
Lot Size
1
Price Forecast

News

Comment

Company Overview More
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
CEO: Dr. Jennifer S. Buell, PhD
Market: NASDAQ
Listing Date: 10/15/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist